Asthma Therapeutics Market Size, Share, Trends, Regional Analysis and Forecast until 2025 | The market is Anticipated to Grow with 1.9% CAGR During 2017-2025

AnalystView Market Insights recently introduced professional in-depth market research report on antifungal drugs market which is available for immediate purchase. The global asthma therapeutics market is expected to grow at the growth rate of 1.9% to reach USD 24.8 billion by 2025. Global asthma therapeutics market study provides comprehensive profiling for key players such as AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Synovium Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH.

This study focuses on the market status, growth projection, key players’ revenue share, drivers, restraints and opportunities with respect to the global asthma therapeutics market. This published report studies global market in terms of drug class, products and route of administration. Also, geographies such as North America, Europe, Asia Pacific, Middle East, and Africa and Latin America are studied in detail.

Asthma and COPD conditions are a major burden on the economy of a nation, especially in countries such as the U.S., China and France. This is due to the rise in number of smokers and increasing pollution. This has fueled government initiatives to educate the people regarding awareness about asthma, and their management as well as funding by various government and non-government agencies, leading to drive the market growth. Other factors such as aging population, rise in healthcare expenditure, increasing research and development initiatives stimulated the market growth. However, expiry of leading branded drugs such as Singulair (montelukast sodium), Symbicort (budesonide/formoterol fumarate), Advair (fluticasone propionate/salmeterol xinafoate), and Xolair (omalizumab) is anticipated to hamper the market growth.

Get access to exclusive PDF brochure of this study @
www.analystviewmarketinsights.com/request_sample/av105/

The global Asthma therapeutics market is segmented on the basis of drug class, product, route of administration and region. On the basis of drug class, the market is segmented into anti- inflammatory, bronchodilators and combination therapy. Anti- inflammatory drugs are expected to witness market growth owing to R&D developments pertaining to biologics. Patent expiration of anti- inflammatory drugs during the forecast period will have impact on the revenue generation.

On the basis of products offered by companies, the market is segmented into inhalers and nebulizers. Inhalers are most widely adopted owing to the patient compliance and ease of administration. They held the leading position in the market. Amongst inhalers, metered dose inhalers have been widely adopted due to their application in the long term therapy. Nebulizers are anticipated to grow at the highest CAGR during the forecast period.

Based on route of administration, the market is segmented into oral, inhaled and other routes. Inhaled route of administration accounted for the largest revenue in the year 2015. This is due to effective pharmacodynamics and pharmacokinetic actions upon administration of drug dose by this route. Oral route of administration is expected to emerge as the fastest growing market over the forecast period. Geographically, the market is represented as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America dominated the overall asthma therapeutics market in terms of revenue share in 2014 at over 50.0%.

Some of the key players in this industry include AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Boehringer Ingelheim GmbH and others.

Click here to obtain more highlight on “Asthma Therapeutics Market, By Drug Class (Anti-inflammatory, Bronchodilators, and Combination Therapy), By Products (Inhalers and Nebulizers), By RoA, and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” study @
www.analystviewmarketinsights.com/report-highlight-asthma-therapeutics-market-105/

The global asthma therapeutics market is segmented on the basis of:

Market, by Drug Class
- Anti-inflammatory
- Bronchodilators
- Combination Therapy

Market, by Products
- Inhalers
- Nebulizers

Market, by Route
- Oral
- Inhaled
- Subcutaneous
- Intravenous

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
- AstraZeneca Plc
- Philips Healthcare
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline Plc
- Sanofi-Aventis SA
- CareFusion Corporation
- Synovium Pharmaceuticals, Inc.
- Boehringer Ingelheim GmbH

USP of our key vendor analysis:
- Well-designed strategic framework design for these key players will help to understand the market movement including regional expansion, mergers & acquisitions, and new product developments
- Thorough SWOT i.e. Strength, Weakness, Opportunities and Threat for individual company profiling is analyzed in order to present a detailed market opportunity assessment.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion
To enquire more about our research process and report store, please connect @
https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.